Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Journal of Autism and Developmental Disorders|December 18, 2013
Comprehensive comparison of self-administered questionnaires for measuring quantitative autistic traits in adultsTakeshi Nishiyama, Masako Suzuki, Katsunori Adachi, et al.
Journal of Synchrotron Radiation|March 1, 2018
Software for the data analysis of the arrival-timing monitor at SACLAKyo Nakajima, Yasumasa Joti, Tetsuo Katayama, et al.
Inflammation and Regeneration|July 12, 2024
Proteomic insights into extracellular vesicles in ALS for therapeutic potential of Ropinirole and biomarker discoveryChris Kato, Koji Ueda, Satoru Morimoto, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 24, 2024
Phenotypic Insights Into Anti-IgLON5 Disease in IgLON5-Deficient MiceSin Yi Lee, Hirotaka Shoji, Aki Shimozawa, et al.
Journal of Adolescence|February 17, 2020
Assessing the hierarchy of personal values among adolescents: A comparison of rating scale and paired comparison methodsYudai Iijima, Yasuyuki Okumura, Syudo Yamasaki, et al.
Brain : a Journal of Neurology|September 23, 2024
Multiple lines of evidence for disruption of nuclear lamina and nucleoporins in FUS amyotrophic lateral sclerosisKensuke Okada, Daisuke Ito, Satoru Morimoto, et al.
Therapeutic Advances in Neurological Disorders|March 28, 2020
Suitable indications of eculizumab for patients with refractory generalized myasthenia gravisMunenori Oyama, Kensuke Okada, Masayuki Masuda, et al.
Journal of Synchrotron Radiation|October 15, 2013
High-speed classification of coherent X-ray diffraction patterns on the K computer for high-resolution single biomolecule imagingAtsushi Tokuhisa, Junya Arai, Yasumasa Joti, et al.
Cell Stem Cell|June 2, 2023
Phase 1/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discoverySatoru Morimoto, Shinichi Takahashi, Daisuke Ito, et al.
Brain Communications|October 11, 2021
Evaluation of [18F]PI-2620, a second-generation selective tau tracer, for assessing four-repeat tauopathiesToshiki Tezuka, Keisuke Takahata, Morinobu Seki, et al.
Pageof 6